
Overview
May Counsilman is a General Surgeon and an Oncologist in Philadelphia, Pennsylvania. Dr. Counsilman is rated as an Experienced provider by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are UPJ Obstruction, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Obstructive Uropathy, and Ureteroscopy. Dr. Counsilman is currently accepting new patients.
Her clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE PDP
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3998 Red Lion Road, Suite 305, Philadelphia, PA 19114
Additional Areas of Focus
Dr. Counsilman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Temple Faculty Practice Plan Inc
Robert Uzzo is an Urologist in Philadelphia, Pennsylvania. Dr. Uzzo is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Renal Oncocytoma, Nephrectomy, and Cystectomy.
Penn Urology Perelman
Thomas Guzzo is an Urologist in Philadelphia, Pennsylvania. Dr. Guzzo is rated as an Elite provider by MediFind in the treatment of Clear Cell Sarcoma. His top areas of expertise are Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Guzzo is currently accepting new patients.
Abramson Cancer Center Perelman 2nd Floor West
Naomi Haas is an Oncologist in Philadelphia, Pennsylvania. Dr. Haas is rated as a Distinguished provider by MediFind in the treatment of Clear Cell Sarcoma. Her top areas of expertise are Renal Cell Carcinoma (RCC), Clear Cell Sarcoma, Chromophobe Renal Cell Carcinoma, and WT1-Related Wilms Tumor Syndromes. Dr. Haas is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute CystitisDr. Counsilman isExperienced. Learn about Acute Cystitis.
- Bilateral HydronephrosisDr. Counsilman isExperienced. Learn about Bilateral Hydronephrosis.
- Bladder CancerDr. Counsilman isExperienced. Learn about Bladder Cancer.
- BoilsDr. Counsilman isExperienced. Learn about Boils.
- CarbuncleDr. Counsilman isExperienced. Learn about Carbuncle.
- Chromophobe Renal Cell CarcinomaDr. Counsilman isExperienced. Learn about Chromophobe Renal Cell Carcinoma.